Birzeit Pharmaceutical Company: Marketing from Palestine Case Solution And Analysis, HBR Case Study Solution & Analysis of Harvard Case Studies

Birzeit Pharmaceutical Company (BPC) was established in 1974. She successfully completed a number of mergers and overcome challenges and phases of development, which led the company to provide a strong position in its domestic market, Palestine and implement a wide range of products in export markets. The continued success of the CCL, despite the political instability and the continuing restrictions on its growth and expansion, has led the company's vision to focus beyond the local presence. Despite the growth of BPC and, financially solid, it was very similar to other Arab businesses that want to invest a lot of money and take greater risks in growing outside their districts. BPC did not want to risk large sums of money to develop the business further, and instead decided to enter new markets or introduce new products niche conservative basis. BPC invested in Algeria's package name Petrapharm in 2006 and designed to meet its vision of growth into new markets and new product introduction. BPC wanted packaging company, later to grow to a production company, and therefore, the export location. In a business environment, which was based on a quick fix by a rapidly growing business in emerging markets and high competition, companies are required to faster decisions to invest more money and choose a new path to ensure its development and business growth. Competition in the pharmaceutical production and especially generics grew massively and the sooner BPC moved, more competitive, it will be. "Hide
by Yara Asad, Ilan Alon Source: Richard Ivey School of Business Foundation 15 pages. Publication Date: February 16, 2011. Prod. # 910A27-PDF-ENG